Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease
Conditions
- Graft Versus Host Disease
Interventions
- DRUG: brentuximab vedotin
- OTHER: laboratory biomarker analysis
- OTHER: pharmacological study
Sponsor
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Collaborators